Relay Therapeutics's total assets for Q1 2025 were $799.36M, a decrease of -8.26% from the previous quarter. RLAY total liabilities were $78.28M for the fiscal quarter, a -16.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.